Course InformationTherapautic Area: Cardiology
Format(s): Meeting Reporter, Downloadable PDF
Credit(s): 1.00 AMA PRA Category 1 Credit(s)™
Activity Dates: January 20, 2016 - January 19, 2017
This discussion-based, CME program will feature imperative information for the treatment and management of patients with heart failure presented at the American Heart Association Scientific Sessions 2016 held in New Orleans, Louisiana. Predictors of heart failure, patient assessment techniques and risk-benefit considerations for patients, both in the initiation of treatment and as treatment progresses, will be discussed. The three expert faculty will review newly released clinical trial data, particularly those pertaining to novel targeted therapeutics. Updates on major outcomes trials and the impending effect on clinical practice will be assessed. After participating in this activity, healthcare professionals will gain insight into optimal, personalized treatment and management strategies as well as methods of improving outcomes in patients with heart failure.
Cardiologists, primary care physicians, and other healthcare professionals who care for patients with heart failure.
- Discuss patient assessment, comorbidities, and risk-benefit considerations for heart failure patients.
- Analyze current clinical trial data for recent targeted therapies presented at AHA 2016.
- Develop optimal therapeutic strategies to improve patient outcomes
Lee R. Goldberg, MD, MPH
University of Pennsylvania Heart Failure and Transplantation Program
Associate Professor of Medicine
University of Pennsylvania School of Medicine